BRCA1 and neoplasm: Specifically, the BRCA1/2 mutant subset of HGSOC are associated with higher neoantigen loads, elevated levels of tumour infiltrating lymphocytes (TILs), and increased expression of immune pathway genes (Strickland et al., 2016).